Age-related macular degeneration (AMD) is a late-onset, neurodegenerative retinal disease that shares several clinical and pathological features with Alzheimer's disease (AD) including extracellular deposits containing amyloid-beta (Abeta) peptides. Immunotherapy targeting the Abeta protein has been investigated as a potential treatment for AD. Here, we present the rationale for extending this approach to treat AMD. We tested an anti-Abeta antibody administered systemically in a mouse model of AMD. Histological and functional measurements in treated animals compared to controls showed that following immunotherapy, the amounts of Abeta in the retina and brain were decreased and the ERG deficits in the retina were attenuated. These data support the hypothesis that Abeta is a therapeutic target for AMD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323206PMC
http://dx.doi.org/10.1016/j.visres.2007.07.025DOI Listing

Publication Analysis

Top Keywords

age-related macular
12
macular degeneration
12
alzheimer's disease
8
mouse model
8
targeting age-related
4
degeneration alzheimer's
4
disease based
4
based immunotherapies
4
immunotherapies anti-amyloid-beta
4
anti-amyloid-beta antibody
4

Similar Publications

Retinal pigment epithelium (RPE) atrophy is a significant cause of human blindness worldwide, occurring in polygenic diseases such as age-related macular degeneration (AMD) and monogenic diseases such as Stargardt diseases (STGD1) and late-onset retinal degeneration (L-ORD). The patient-induced pluripotent stem cells (iPSCs)-derived RPE (iRPE) model exhibits many advantages in understanding the cellular basis of pathological mechanisms of RPE atrophy. The iRPE model is based on iPSC-derived functionally mature and polarized RPE cells that reproduce several features of native RPE cells, such as phagocytosis of photoreceptor outer segments (POS) and replenishment of visual pigment.

View Article and Find Full Text PDF

The smaller-incision new-generation implantable miniature telescope (SING IMT) represents an advancement over the previous model, WA-IMT, serving as a unilateral prosthetic device for patients with late-stage age-related macular degeneration (AMD). This study aims to report changes in multifocal electroretinography (mfERG) 6 months post-SING IMT implantation. In this case series, we prospectively evaluated a cohort of phakic patients with late-stage AMD who underwent SING IMT implantation at the Ophthalmology Unit, University of Bari Aldo Moro, Italy.

View Article and Find Full Text PDF

Background: Age-related macular degeneration (AMD) is a significant factor causing blindness in adults. However, the clinical diagnosis of AMD is relatively challenging, due to the shortcomings of the existing clinical examination methods and the latent period of retinal damage before macular degeneration becomes apparent. This study aims to explore the potential of extracellular vesicles (EVs) protein chips for early diagnosis of AMD using patients' plasma samples.

View Article and Find Full Text PDF

Exploring Ocular Disorders in Parkinson's Disease: A Comprehensive Review and Future Perspectives.

Exp Eye Res

December 2024

Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong; Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Kowloon, Hong Kong; Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Kowloon, Hong Kong. Electronic address:

Article Synopsis
  • Parkinson's disease (PD) is primarily known for its motor symptoms, but research is highlighting its significant effects on non-motor functions, particularly ocular health.
  • This review discusses the connection between PD and various common eye diseases, including dry eye disease and cataracts, emphasizing that these ocular issues can serve as early indicators of PD.
  • Future studies should focus on exploring links between PD and additional eye conditions, like myopia, to develop better treatment approaches for patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!